Doyoumoney

	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17
Total cash and short-term investments +	462.86	905.35	1,522.41	2,402.04	708.15	736.86	383.44	98.44	187.92
Cash and cash equivalents	234.11	222.95	241.58	848.63	347.82	436.58	109.34	47.60	187.92
Short-term investments	228.75	682.40	1,280.83	1,553.41	360.33	300.29	274.10	50.85	0.00
Accounts receivable, net	3.60	5.10	11.60	26.40	773.08	1.90
Inventories					8.59			0.00	0.00
Other current assets	47.62	137.11	65.82	117.04	81.60	35.50	13.38	19.34	4.43
Total current assets	514.08	1,042.46	1,588.23	2,519.08	1,562.82	772.37	403.00	117.78	192.35
Total non-current assets +	488.74	356.33	330.83	283.01	391.45	146.40	109.08	73.81	59.22
Property, plant and equipment, net				188.17	130.05	17.95	16.31	12.29	5.14
Goodwill	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94
Intangible assets	7.85	8.10	22.57	32.76	33.29	33.82	35.69	36.92	35.88
Long-term investments	314.58	190.02	105.28	23.93	201.39	0.00	24.29	6.60	0.00
Other non-current assets
Total assets	1,002.82	1,398.81	1,919.06	2,802.09	1,954.27	918.76	512.07	191.60	251.57

Total current liabilities +	92.82	119.66	175.41	511.03	341.24	99.06	59.21	39.91	12.44
Accounts payable	9.80	5.08	6.33	6.42	6.52	5.08	5.88	6.47	4.90
Short-term debt	8.80	7.75	12.87	4.14	3.93	3.63	0.24	14.53	0.00
Current portion of long-term debt								0.00	0.00
Deferred revenue
Other current liabilities	74.21	94.18	91.20	469.73	226.37	83.91	46.91	24.67	7.54
Total non-current liabilities +	144.73	128.77	153.42	213.10	181.18	102.85	28.92	330.87	308.04
Long-term debt								0.00	0.00
Capital lease obligations	97.85	97.89	124.54	123.84	133.56	70.45	0.24	0.00	0.00
Other non-current liabilities	55.68	38.63	40.22	32.80	25.36	95.78	12.95	10.84	10.40
Total liabilities	237.55	248.43	328.82	724.13	522.42	201.91	88.13	370.77	320.48

Total stockholders' equity +	765.28	1,150.39	1,590.24	2,077.96	1,431.85	716.85	423.94	-179.18	-68.92
Common stock and paid-in capital	1,963.05	1,910.17	1,828.06	1,700.73	1,570.45	1,384.04	792.46	14.66	9.04
Retained earnings	-1,197.77	-759.78	-237.82	377.24	-138.60	-667.18	-368.52	-193.84	-77.95
Common shares outstanding	139	136	134	135	133	119	108	97	7

Show Quarterly Balance Sheet

	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	Mar-24	Dec-23	Sep-23	Jun-23	Mar-23	Dec-22	Sep-22	Jun-22	Mar-22	Dec-21	Sep-21	Jun-21	Mar-21	Dec-20	Sep-20	Jun-20	Mar-20	Dec-19	Sep-19	Jun-19	Mar-19	Dec-18	Sep-18	Jun-18	Mar-18
Total cash and short-term investments +	472.36	462.86	506.51	606.02	801.66	905.35	914.47	1,151.07	1,149.76	1,522.41	1,696.55	1,847.43	2,250.08	2,402.04	2,346.48	2,195.70	1,260.07	708.15	939.45	826.06	733.03	736.86	826.60	552.38	355.61	383.44	320.21	356.55	98.44	98.44	0.00	0.00	187.92
Cash and cash equivalents	276.09	234.11	170.08	211.10	273.57	222.95	168.35	296.86	160.71	241.58	452.10	666.95	824.91	848.63	963.74	1,505.18	812.36	347.82	714.52	741.95	521.40	436.58	462.52	371.78	168.42	109.34	93.70	80.68	-98.44	47.60			-187.92
Short-term investments	196.28	228.75	336.43	394.92	528.09	682.40	746.12	854.20	989.05	1,280.83	1,244.45	1,180.48	1,425.16	1,553.41	1,382.75	690.52	447.72	360.33	224.93	84.11	211.64	300.29	364.07	180.60	187.19	274.10	226.51	275.87	196.89	50.85			375.84
Accounts receivable, net		3.60	4.00	5.20		5.10	5.30	7.20	9.80	11.60	4.80	13.00	17.90	26.40	6.21	7.00	1,223.16	773.08	93.00	0.60	225.00	1.90		3.80				0.00	0.00				0.00
Inventories							-5.30	0.00			8.39	0.16	-6.94			0.00	0.00	8.59	6.11	6.40	8.60							0.00	0.00				0.00
Other current assets	50.62	47.62	39.17	129.69	130.55	132.01	132.68	54.68	63.33	65.82	72.62	98.90	108.56	117.04	67.14	85.56	84.31	81.60	33.88	36.24	35.08	35.50	22.98	26.38	21.93	13.38	8.69	20.85	11.62	19.34			0.00
Total current assets	522.99	514.08	545.68	735.71	932.21	1,042.46	1,047.16	1,205.74	1,213.10	1,588.23	1,769.18	1,946.33	2,358.63	2,519.08	2,413.62	2,288.27	2,567.55	1,562.82	1,066.34	862.30	993.11	772.37	849.57	578.76	377.54	403.00	337.72	377.40	98.44	117.78			187.92
Total non-current assets +	502.60	488.74	473.77	456.83	375.52	356.33	451.20	463.82	580.87	330.86	275.72	297.54	307.30	283.01	282.35	330.73	319.58	391.45	143.88	195.29	142.47	146.40	93.69	93.48	99.57	109.08	84.92	79.45	-98.44	73.81			-187.92
Property, plant and equipment, net												104.13	103.76	188.17	100.23	85.14	65.58	130.05	26.61	20.25	17.29	17.95	31.71	31.49	32.25	16.31	15.45	15.42	15.42				0.00
Goodwill	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94	16.94			0.00
Intangible assets	7.78	7.85	7.92	8.00	8.07	8.10	19.26	18.90	22.47	22.59	25.46	25.59	32.62	32.76	32.89	33.02	33.15	33.29	33.42	33.55	33.69	33.82	33.95	35.08	35.39	35.69	36.00	36.31	36.31	36.92			0.00
Long-term investments	332.97	314.58	304.21	286.10	218.14	190.02	271.50	279.99	359.72	105.28	39.62	52.36	49.19	23.93	34.10	97.59	103.54	201.39		50.68		0.00	0.00	0.00	6.14	24.29	6.60	6.60	6.60				0.00
Other non-current assets
Total assets	1,025.59	1,002.82	1,019.45	1,192.53	1,307.73	1,398.81	1,498.36	1,669.56	1,793.97	1,919.06	2,044.90	2,243.87	2,665.94	2,802.09	2,695.97	2,618.99	2,887.13	1,954.27	1,210.21	1,057.58	1,135.58	918.76	943.26	672.24	477.11	512.07	422.64	456.85	456.85	191.60			0.00

Total current liabilities +	73.56	92.82	75.22	105.00	137.29	119.66	117.16	96.41	94.07	175.41	165.05	225.62	485.29	511.03	308.20	477.87	702.36	341.24	233.72	146.02	361.10	99.06	77.00	54.94	56.40	59.21	44.32	40.72	40.72	39.91			0.00
Accounts payable	5.45	9.80	6.85	12.23	3.73	5.08	7.31	4.39	7.11	6.33	3.63	12.36	12.15	6.42	2.72	10.62	10.96	6.52	4.23	11.03	3.70	5.08	6.80	4.38	18.77	5.88	5.82	4.08	4.08	6.47			0.00
Short-term debt		8.80	8.96	8.83	7.93	7.75	19.41	19.50	11.91	12.87	13.56	13.54	7.27	4.14	4.12	4.10	4.07	3.93	3.55	3.52	3.57	3.63	3.71	3.38	3.41	0.24	22.95	18.37	0.00	14.53			0.00
Current portion of long-term debt																												0.00	0.00				0.00
Deferred revenue
Other current liabilities	68.11	74.21	59.42	73.84	113.70	94.18	75.25	55.81	60.20	91.20	117.14	168.55	433.40	469.73	180.31	192.45	169.17	226.37	129.79	86.75	90.90	83.91	60.93	39.88	29.21	46.91	6.73	36.64	18.27	24.67			0.00
Total non-current liabilities +	139.26	144.73	148.13	140.06	126.62	128.77	140.47	139.47	152.55	153.42	204.76	208.04	209.85	213.10	237.91	189.11	183.75	181.18	100.22	174.23	123.53	102.85	53.91	53.52	40.39	28.92	659.12	14.68	0.00	330.87			0.00
Long-term debt																												0.00	0.00				0.00
Capital lease obligations	95.58	97.85	100.18	102.23	96.10	97.89	112.81	114.51	121.08	124.54	114.12	117.82	121.46	123.84	126.94	134.31	136.88	133.56	72.16	72.46	70.18	70.45	15.80	16.14	16.94	0.24		0.00	0.00				0.00
Other non-current liabilities	52.63	55.68	47.49	46.65	38.45	38.63	47.06	44.46	41.85	40.22	37.43	37.02	31.93	32.80	37.88	36.05	159.45	25.36	93.15	115.48	116.47	95.78	34.69	33.64	16.99	12.95	6.37	4.81	0.00				0.00
Total liabilities	212.82	237.55	223.36	245.06	263.91	248.43	257.63	235.89	246.61	328.82	369.81	433.67	695.14	724.13	546.12	666.98	886.12	522.42	333.94	320.26	484.63	201.91	130.90	108.46	96.78	88.13	703.44	55.40	55.40	370.77			0.00

Total stockholders' equity +	812.77	765.28	796.10	947.47	1,043.82	1,150.39	1,240.73	1,433.67	1,547.36	1,590.24	1,675.09	1,810.21	1,970.76	2,077.96	2,149.86	1,952.01	2,001.01	1,431.85	876.27	737.33	650.95	716.85	812.36	563.78	380.33	423.94	-280.80	401.45	130.98	-179.18			224.54
Common stock and paid-in capital	2,136.23	1,963.05	1,950.95	1,939.18	1,924.57	1,910.17	1,895.92	1,875.15	1,850.46	1,828.06	1,796.94	1,768.65	1,734.42	1,700.73	1,671.02	1,648.48	1,620.99	1,570.45	1,540.13	1,511.61	1,487.05	1,384.04	1,373.89	1,040.71	826.09	792.46	23.95	657.89	387.42	14.66	0.00	0.00	224.54
Retained earnings	-1,323.47	-1,197.77	-1,154.85	-991.71	-880.75	-759.78	-655.20	-441.48	-303.10	-237.82	-121.85	41.56	236.34	377.24	478.84	303.53	380.02	-138.60	-663.85	-774.28	-836.10	-667.18	-561.54	-476.93	-445.76	-368.52	-304.75	-256.43	-256.43	-193.84			0.00
Common shares outstanding	147	139	139	138	137	137	137	136	135	135	134	134	134	133	135	132	135	134	134	134	128	127	126	115	108	92	109	109	97	97	97	7	7

Balance Sheet - Vir Biotechnology, Inc. (VIR)

Balance Sheet - Vir Biotechnology, Inc. (VIR)